Stryker Net Worth
Stryker Net Worth Breakdown | SYK |
Stryker Net Worth Analysis
Stryker's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Stryker's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Stryker's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Stryker's net worth analysis. One common approach is to calculate Stryker's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Stryker's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Stryker's net worth. This approach calculates the present value of Stryker's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Stryker's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Stryker's net worth. This involves comparing Stryker's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Stryker's net worth relative to its peers.
Enterprise Value |
|
To determine if Stryker is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Stryker's net worth research are outlined below:
| Over 80.0% of the company shares are owned by institutional investors | |
| On 31st of October 2024 Stryker paid $ 0.8 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Stryker Stock May Gain From Oculan Lighting Platforms Launch |
Stryker Quarterly Good Will |
|
Stryker uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Stryker. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Stryker's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 30th of January 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Stryker's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Stryker is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stryker backward and forwards among themselves. Stryker's institutional investor refers to the entity that pools money to purchase Stryker's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 5.7 M | Fundsmith Llp | 2024-09-30 | 5.3 M | Norges Bank | 2024-06-30 | 5 M | Franklin Resources Inc | 2024-06-30 | 4.4 M | Fisher Asset Management, Llc | 2024-09-30 | 4.2 M | First Western Trust Bank | 2024-09-30 | 3.5 M | Bank Of America Corp | 2024-06-30 | 3.2 M | Northern Trust Corp | 2024-09-30 | 3.2 M | Legal & General Group Plc | 2024-06-30 | 2.8 M | Vanguard Group Inc | 2024-09-30 | 32.4 M | Blackrock Inc | 2024-06-30 | 26.8 M |
Follow Stryker's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 148.73 B.Market Cap |
|
Project Stryker's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.12 | 0.21 | |
| Return On Assets | 0.08 | 0.11 | |
| Return On Equity | 0.17 | 0.19 |
When accessing Stryker's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Stryker's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Stryker's profitability and make more informed investment decisions.
Evaluate Stryker's management efficiency
Stryker has Return on Asset of 0.0711 % which means that on every $100 spent on assets, it made $0.0711 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1887 %, implying that it generated $0.1887 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Stryker's Return On Capital Employed is quite stable compared to the past year. Return On Assets is expected to rise to 0.11 this year, although the value of Return On Tangible Assets will most likely fall to 0.10. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 41.9 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 48.98 | 51.43 | |
| Tangible Book Value Per Share | (3.27) | (3.11) | |
| Enterprise Value Over EBITDA | 23.97 | 12.99 | |
| Price Book Value Ratio | 6.11 | 6.37 | |
| Enterprise Value Multiple | 23.97 | 12.99 | |
| Price Fair Value | 6.11 | 6.37 | |
| Enterprise Value | 111.3 B | 116.9 B |
The strategic vision of Stryker management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 7.1825 | Revenue 22 B | Quarterly Revenue Growth 0.119 | Revenue Per Share 57.728 | Return On Equity 0.1887 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Stryker insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Spencer Stiles over three months ago Acquisition by Spencer Stiles of 8499 shares of Stryker subject to Rule 16b-3 | ||
Yin Becker over six months ago Acquisition by Yin Becker of 3060 shares of Stryker at 339.77 subject to Rule 16b-3 | ||
Ramesh Subrahmanian over a year ago Payment of 2378 shares by Ramesh Subrahmanian of Stryker subject to Rule 16b-3 |
Stryker Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 30th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of September 2024 Certification of the accuracy of the financial statements and disclosures | ViewVerify |
Stryker Earnings per Share Projection vs Actual
Stryker Corporate Directors
| Andrew Silvernail | Independent Director | Profile | |
| Sherilyn McCoy | Independent Director | Profile | |
| Ronda Stryker | Independent Director | Profile | |
| Allan Golston | Lead Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 3.2 | Earnings Share 9.32 | Revenue Per Share 57.728 | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.